A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection.
Administration of Paxlovid during a SARS-CoV-2 infection has previously been linked to a lower risk of developing long COVID symptoms. But a study published in the Nature science journal suggests taking the treatment may have benefits for people with long COVID when they're not experiencing an active infection.
...
Заголовки